P. Lesca

1.9k total citations
68 papers, 1.7k citations indexed

About

P. Lesca is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, P. Lesca has authored 68 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 29 papers in Oncology and 24 papers in Pharmacology. Recurrent topics in P. Lesca's work include Pharmacogenetics and Drug Metabolism (23 papers), Cancer therapeutics and mechanisms (18 papers) and Drug Transport and Resistance Mechanisms (15 papers). P. Lesca is often cited by papers focused on Pharmacogenetics and Drug Metabolism (23 papers), Cancer therapeutics and mechanisms (18 papers) and Drug Transport and Resistance Mechanisms (15 papers). P. Lesca collaborates with scholars based in France, Morocco and China. P. Lesca's co-authors include P. Lecointe, Claude Paoletti, Daniel Mansuy, Patrick Maurel, G Fourtanier, J Domergue, P. Galtier, G. Larrieu, C. Delescluse and Roger Rahmani and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

P. Lesca

67 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Lesca France 23 688 668 423 420 378 68 1.7k
Dennis V. Parke United Kingdom 23 699 1.0× 547 0.8× 233 0.6× 308 0.7× 340 0.9× 110 1.9k
James S. Felton United States 20 453 0.7× 647 1.0× 323 0.8× 472 1.1× 891 2.4× 37 1.9k
Naok̆i Ozawa Japan 24 596 0.9× 666 1.0× 237 0.6× 254 0.6× 378 1.0× 71 1.8k
P. Millburn United Kingdom 23 546 0.8× 442 0.7× 608 1.4× 339 0.8× 204 0.5× 76 1.9k
Henry P. Ciolino United States 22 436 0.6× 904 1.4× 299 0.7× 376 0.9× 339 0.9× 34 2.1k
Hira L. Gurtoo United States 28 674 1.0× 818 1.2× 303 0.7× 286 0.7× 863 2.3× 83 2.1k
Marilyn C. Henderson United States 23 865 1.3× 660 1.0× 146 0.3× 445 1.1× 151 0.4× 53 1.9k
Linda C. Quattrochi United States 26 1.5k 2.2× 872 1.3× 736 1.7× 432 1.0× 488 1.3× 48 2.7k
Walter Meinl Germany 29 760 1.1× 1.1k 1.6× 278 0.7× 462 1.1× 608 1.6× 64 2.5k
Gregory L. Kedderis United States 21 440 0.6× 358 0.5× 157 0.4× 292 0.7× 440 1.2× 43 1.4k

Countries citing papers authored by P. Lesca

Since Specialization
Citations

This map shows the geographic impact of P. Lesca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Lesca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Lesca more than expected).

Fields of papers citing papers by P. Lesca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Lesca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Lesca. The network helps show where P. Lesca may publish in the future.

Co-authorship network of co-authors of P. Lesca

This figure shows the co-authorship network connecting the top 25 collaborators of P. Lesca. A scholar is included among the top collaborators of P. Lesca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Lesca. P. Lesca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lemaire, G., C. Delescluse, M. Pralavorio, et al.. (2004). The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes. Life Sciences. 74(18). 2265–2278. 58 indexed citations
2.
Ledirac, Nathalie, C. Delescluse, P. Lesca, et al.. (2000). Diflubenzuron, a Benzoyl-Urea Insecticide, Is a Potent Inhibitor of TCDD-Induced CYP1A1 Expression in HepG2 Cells. Toxicology and Applied Pharmacology. 164(3). 273–279. 10 indexed citations
3.
Fontaine, Frank, C. Delescluse, Georges de Sousa, P. Lesca, & Roger Rahmani. (1999). Cytochrome 1A1 induction by primaquine in human hepatocytes and HepG2 cells: absence of binding to the aryl hydrocarbon receptor. Biochemical Pharmacology. 57(3). 255–262. 39 indexed citations
4.
Lesca, P., et al.. (1999). Hepatic Ah receptor binding affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin: similarity between beagle dog and cynomolgus monkey. Toxicology Letters. 109(1-2). 115–121. 5 indexed citations
5.
Lesca, P., et al.. (1998). The 8S Benzo(a)pyrene-Binding Protein Is an Aldehyde Dehydrogenase Regulated by the Ah Receptor. Biochemical and Biophysical Research Communications. 242(1). 26–31. 6 indexed citations
6.
Costet, Philippe, et al.. (1998). The 4S Benzo(a)pyrene-Binding Protein Is Not a Transcriptional Activator ofCyp1a1Gene in Ah Receptor-Deficient (AHR −/−) Transgenic Mice. Archives of Biochemistry and Biophysics. 349(2). 349–355. 11 indexed citations
8.
Lesca, P., G. Larrieu, M. Alvinerie, et al.. (1995). Evidence for the Ligand-Independent Activation of the AH Receptor. Biochemical and Biophysical Research Communications. 209(2). 474–482. 75 indexed citations
9.
Lesca, P., Renger F. Witkamp, Patrick Maurel, & P. Galtier. (1994). The Pig as a Model for Studying AH Receptor and Other PAH-Binding Proteins In Man. Biochemical and Biophysical Research Communications. 200(1). 475–481. 14 indexed citations
10.
Lesca, P., et al.. (1993). Detection and Characterization of a Novel Hepatic 8 S Binding Protein for Benzo[a]Pyrene Distinct from the Ah Receptor. Archives of Biochemistry and Biophysics. 303(1). 114–124. 7 indexed citations
11.
Rivière, J.L., et al.. (1992). Induction and characterization of cytochromes P450IA and -IIB in the newt, Pleurodeles waltl. Ecotoxicology and Environmental Safety. 24(2). 144–154. 18 indexed citations
12.
Lesca, P., et al.. (1992). Mechanism of antimutagenicity of wheat sprout extracts. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 269(2). 201–215. 49 indexed citations
13.
Daujat‐Chavanieu, Martine, et al.. (1992). Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor. Biochemical and Biophysical Research Communications. 188(2). 820–825. 115 indexed citations
14.
Maurel, Patrick, et al.. (1992). Characterization of the 4 S polycyclic aromatic hydrocarbon-binding protein in human liver and cells. Archives of Biochemistry and Biophysics. 298(2). 420–430. 3 indexed citations
15.
Souès, Sylvie, et al.. (1989). Separation of the different classes of intrahepatic lipoproteins from various animal species. Biochemical Pharmacology. 38(17). 2833–2839. 5 indexed citations
16.
Lesca, P., et al.. (1988). Binding characteristics of Ah receptors from rats and mice before and after separation from hepatic cytosols. European Journal of Biochemistry. 172(3). 585–592. 24 indexed citations
17.
Lesca, P., et al.. (1988). Binding characteristics of 4‐S proteins from rat and mouse liver High affinity of ellipticines. European Journal of Biochemistry. 172(3). 593–599. 24 indexed citations
18.
Lesca, P., et al.. (1984). A dual assay for the specific screening of 3-methylcholanthrene- and phenobarbital-like chemical inducers of cytochrome P-450 monooxygenases. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 129(3). 299–310. 10 indexed citations
20.
Lesca, P., P. Lecointe, Claude Paoletti, & Daniel Mansuy. (1976). Induction des mono-oxygénases hépatiques par l'ellipticine chez le Rat: Formation de cytochrome P448. Activité hydroxylante. Comptes rendus hebdomadaires des séances de l Académie des sciences. 282(15). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026